oxamniquine has been researched along with Hypertension, Portal in 5 studies
Oxamniquine: An anthelmintic with schistosomicidal activity against Schistosoma mansoni, but not against other Schistosoma spp. Oxamniquine causes worms to shift from the mesenteric veins to the liver where the male worms are retained; the female worms return to the mesentery, but can no longer release eggs. (From Martindale, The Extra Pharmacopoeia, 31st ed, p121)
oxamniquine : A racemate comprising equimolar amounts of (R)- and (S)-oxamniquine. An anthelmintic, it is administered orally for the treatment of schistomiasis caused by Schistosoma mansoni (but not by other Schistosoma species); intramuscular administration is no longer used as it causes severe pain at the injection site.
{2-[(isopropylamino)methyl]-7-nitro-1,2,3,4-tetrahydroquinolin-6-yl}methanol : A member of the class of quinolines that is 1,2,3,4-tetrahydroquinoline which is substituted at positions 2, 6, and 7 by (isopropylamino)methyl, hydroxymethyl, and nitro groups, respectively.
Hypertension, Portal: Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oxamniquine-treated at day 70 and measured at day 160 7." | 5.32 | On the increase of portal pressure during the acute and chronic phases of murine schistosomiasis mansoni and its reversibility after treatment with oxamniquine. ( Aguiar, BG; Coelho, PM; Costa, G; Cunha-Melo, JR, 2003) |
| "Oxamniquine-treated at day 70 and measured at day 160 7." | 1.32 | On the increase of portal pressure during the acute and chronic phases of murine schistosomiasis mansoni and its reversibility after treatment with oxamniquine. ( Aguiar, BG; Coelho, PM; Costa, G; Cunha-Melo, JR, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costa, G | 1 |
| Aguiar, BG | 1 |
| Coelho, PM | 1 |
| Cunha-Melo, JR | 1 |
| Alves, JG | 1 |
| Ulisses Montenegro, FM | 1 |
| El-Hawey, AM | 1 |
| Gaber, A | 1 |
| Saber, MA | 1 |
| Abou-Taleb, S | 1 |
| Kloetzel, K | 1 |
| Schuster, NH | 1 |
| el-Rooby, A | 1 |
1 review available for oxamniquine and Hypertension, Portal
| Article | Year |
|---|---|
Management of hepatic schistosomiasis.
Topics: Acute Disease; Animals; Central Nervous System; Child; Chronic Disease; Colon; Diagnosis, Differenti | 1985 |
4 other studies available for oxamniquine and Hypertension, Portal
| Article | Year |
|---|---|
On the increase of portal pressure during the acute and chronic phases of murine schistosomiasis mansoni and its reversibility after treatment with oxamniquine.
Topics: Animals; Hypertension, Portal; Male; Mice; Oxamniquine; Schistosomiasis mansoni; Schistosomicides | 2003 |
Portal hypertension due to schistosomiasis.
Topics: Child, Preschool; Female; Humans; Hypertension, Portal; Liver Diseases, Parasitic; Oxamniquine; Schi | 2001 |
Studies on portal hypertension and its relation to serum histamine level in patients with bilharzial hepatic fibrosis.
Topics: Antimony Potassium Tartrate; Histamine; Humans; Hypertension, Portal; Liver; Liver Diseases, Parasit | 1978 |
Repeated mass treatment of schistosomiasis mansoni: experience in hyperendemic areas of Brazil. I. Parasitological effects and morbidity.
Topics: Adolescent; Adult; Age Factors; Brazil; Humans; Hypertension, Portal; Middle Aged; Nitroquinolines; | 1987 |